🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will assess the efficacy and safety of mosunetuzumab in combinat...
Status
Active Not Recruiting
Location
City of Hope Cancer Center
Start Date
2022-04-25
Trial ID
NCT05171647
Treatments Being Tested
This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2023-06-12
Trial ID
NCT05633615
This study will evaluate the efficacy and safety of mosunetuzumab in combin...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2021-10-27
Trial ID
NCT04712097
Treatments Being Tested
This study is a phase III, randomized, open-label, international, multicent...
Status
Recruiting
Location
Krankenhaus der Barmherzigen Brüder Graz - Abteilung Für Innere Medizin I
Start Date
2024-06-07
Trial ID
NCT06284122
The research study is being conducted to test the safety and effectiveness ...
Status
Recruiting
Location
University of Nebraska Medical Center
Start Date
2021-11-05
Trial ID
NCT04889716
Treatments Being Tested
This phase I trial studies the side effects and best dose of mosunetuzumab ...
Status
Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2024-05-20
Trial ID
NCT06015880
The purpose of this prospective, multicenter, Phase 2 study is to evaluate ...
Status
Recruiting
Location
Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences
Start Date
2026-04-10
Trial ID
NCT07555470
Treatments Being Tested
This study will evaluate the safety, tolerability, pharmacokinetics, pharma...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham School of Medicine
Start Date
2018-09-25
Trial ID
NCT03671018
Treatments Being Tested
This phase II trial tests how well pirtobrutinib and mosunetuzumab work in ...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2025-11-17
Trial ID
NCT06948786
This phase II trial compares the effect of mosunetuzumab alone to mosunetuz...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-10-03
Trial ID
NCT07638722